Clonazepam has long been regarded as among the best-proven therapies for lengthy-expression neurological and psychiatric care due to its precision mechanism of action, extended half-daily life and tested medical dependability. Its capability to selectively bind to GABA-A receptors and stabilize hyperactive neural pathways causes it to be a cornerst